No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Female
-
Humans
-
Incidence
-
Macular Degeneration / drug therapy*
-
Male
-
Middle Aged
-
Ranibizumab
-
Selection Bias
-
Thromboembolism / epidemiology*
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Ranibizumab